New York Biotechnology Association (NYBA), the voice of New York State’s biotechnology industry, today announced the line-up of presenting companies in the 2010 Bioscience Corporate Showcase, a special element of the NYBA 2010 Annual Meeting, April 19-20, at the Marriott Marquis Hotel in Times Square.

 

The 15 companies presenting in the Showcase on Monday, April 19 are:

·      9:20 am         Pfizer Worldwide Business Development

·      9:40 am         Psychogenics (neurobiology and CNS drug discovery)

·      10:00 am       Nanoviricides (nano-biopharmaceutical anti-virals)

·      10:40 am       PCAsso Diagnostics (retinal imaging diagnostics)

·      11:00 am       Ancora Pharmaceuticals (novel immune modulation therapeutics and vaccines using synthetic carbohydrates)

·      11:20 am       Rheonix (microfluidics)

·      11:40 am       NeoStem (adult stem cell)

·      12:00-2:00    Plenary lunch program featuring Dr. Christoph Hergersberg, Global Technology Leader, Bioscience, GE Global Research; and The Honorable James Greenwood, President and CEO, Biotechnology Industry Organization (BIO)

·      2:20 pm         Cornerstone Pharmaceuticals (cancer therapies)

·      2:40 pm         Immune Pharmaceuticals (cancer, auto-immune diseases and infectious diseases)

·      3:00 pm         TechnoVax (vaccine development using Virus-Like Particle (VLP) technology)

·      3:40 pm         Acorda Therapeutics (spinal cord injury, MS and CNS conditions)

·      4:00 pm         Curemark (autism and other neurological conditions)

·      4:40 pm         Katalin Polgar

·      5:00-7:00       Gala Reception

 

The NYBA 2010 Annual Meeting will be held April 19-20 at the Marriott Marquis Hotel in Times Square. To see the full conference program and to register, go to www.nyba.org. Speakers and panelists representing more than 150 companies will discussion the issues and opportunities available to New York’s bioscience industry.

 

The NYBA 2010 Annual Meeting program, which can be seen at www.nyba.org, will highlight more than 30 panel sessions on key industry topics, including Drugs, Diagnostics and Medical Devices; Advances in Bioscience; Investment and Financial Issues; The Business of Biotech; Regulatory and Policy Challenges; and Legal and IP Issues.

 

In addition to the Bioscience Corporate Showcase and luncheon speakers, the program will feature keynote addresses from

 

Concurrently, in the Innovation Alley Poster Session, the next generation of scientists and emerging companies will exhibit their groundbreaking scientific research, work that will enable the next great bioscience discovery.

 

In all, more than 650 attendees will converge on the Marriott Marquis to learn, network, discuss, contemplate, debate and engage. 

 

The NYBA Annual Meeting brings together hundreds of bioscience professionals from the New York, the Northeast and the world for two days of high-energy insight and information. For more information go to www.nyba.org or contact Patricia Waddington, NYBA Membership Director, at 631-444-8895.

# # #

 

NYBA is the leading advocate for advancing the success of the biotechnology industry in New York State and is its main representative to state policy makers, the media and communities. NYBA’s mission is to support the development and growth of New York’s biotechnology industry, and serve our members and the biotechnology community by providing a network for information exchange, shared services and collective action.  NYBA’s membership comprises bioscience companies, world-class research institutions and related professional services. Under the banner of The Cures Start Here®, the Association’s goal is to amplify the success New York has had and continues to have in discovering major medical advances and growing a vibrant biotech industry.